新型冠状病毒肺炎疫情期间新生儿遗传代谢性疾病筛查专家共识  

Consensus for Newborn Screening of Inherited Metabolic Disorders during the Coronavirus Disease 2019 Epidemic

作　　者：王冬娟[1] 刘姗[1] 杨静[1] 刘浩[1] 何晓燕[1] 万科星 袁召建[1] 曲一平 欧明才[3] 朱文斌[4] 王洁 赵德华[6] 王维鹏[7] 王治国[8] 邹琳[1] Wang Dongjuan;Liu Shan;Yang Jing;Liu Hao;He Xiaoyan;Wan Kexing;Yuan Zhaojian;Qu Yiping;Ou Mingcai;Zhu Wenbin;Wang Jie;Zhao Dehua;Wang Weipeng;Wang Zhiguo;Zou Lin(Children’s Hospital of Chongqing Medical University,National Clinical Research Center for Child Health and Disorders,Ministry of Education Key Laboratory of Child Development and Disorders,Chongqing Key Laboratory of Pediatrics,Chongqing 400014,China;Children’s Hospital of Zhejiang Medical University,Zhejiang Hangzhou 310000,China;Sichuan Maternal and Child Health Care Hospital,Sichuan Chengdu 610000,China;Fujian Maternal and Child Health Care Hospital,Fujian Fuzhou 350000,China;Hainan Women’s and Children’s Medical Center,Hainan Haikou 570100,China;Henan Maternal and Child Health Hospital/The Third Affiliated Hospital of Zhengzhou University,Henan Zhengzhou 450000,China;Hubei Maternal and Child Health Hospital,Hubei Wuhan 430000,China;Clinical Laboratory Center of National Health Commission/Beijing Hospital,Beijing 100000,China)

机构地区：[1]重庆医科大学附属儿童医院,国家儿童健康与疾病临床医学研究中心,儿童发育疾病研究教育部重点实验室,儿科学重庆市重点实验室,重庆400014 [2]浙江医科大学附属儿童医院,浙江杭州310000 [3]四川省妇幼保健院,四川成都610000 [4]福建省妇幼保健院,福建福州350000 [5]海南省妇女儿童医学中心,海南海口570100 [6]河南省妇幼保健院/郑州大学第三附属医院,河南郑州450000 [7]湖北省妇幼保健院,湖北武汉430000 [8]国家卫生健康委临床检验中心/北京医院,北京100000

出　　处：《儿科药学杂志》2021年第10期47-49,共3页Journal of Pediatric Pharmacy

摘　　要：2019年底出现的新型冠状病毒(2019-nCoV)感染在全国多地及世界各国陆续发生,至今尚未完全控制,已有儿童甚至新生儿感染的报道,中国每年约1 500万新生儿出生,需要进行遗传代谢性疾病新生儿筛查,存在潜在风险。结合现状,重庆医科大学附属儿童医院新生儿疾病筛查中心联合国家卫生健康委员会临床检验中心新生儿疾病筛查室间质评专业委员会的部分专家,经过讨论,提出新型冠状病毒肺炎(COVID-19)疫情期间新生儿遗传代谢性疾病的筛查、诊治及随访的系统建议。The 2019 novel coronavirus(2019-nCoV) infection that emerged at the end of 2019 has been occurring in many places and countries all over the world, and has not yet been fully controlled, with infections in children and even newborns having been reported. Approximately 15 million newborns are born each year in China, and there is a potential risk of newborn screening for inherited metabolic disorders. Based on the current status, some experts from the newborn screening center of Children’s Hospital of Chongqing Medical University and Clinical Laboratory Center of National Health Commission formulate the contingency suggestion for screening, diagnosis, treatment and follow-up of newborn screening of inherited metabolic disorders during the coronavirus disease 2019(COVID-2019) epidemic.

关 键 词：新型冠状病毒 新生儿 疾病筛查 遗传代谢性疾病 

分 类 号：R722.1[医药卫生—儿科]